562 related articles for article (PubMed ID: 16452201)
1. Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation.
Zetser A; Bashenko Y; Edovitsky E; Levy-Adam F; Vlodavsky I; Ilan N
Cancer Res; 2006 Feb; 66(3):1455-63. PubMed ID: 16452201
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation of vascular endothelial growth factor in breast cancer cells by the heregulin-beta1-activated p38 signaling pathway enhances endothelial cell migration.
Xiong S; Grijalva R; Zhang L; Nguyen NT; Pisters PW; Pollock RE; Yu D
Cancer Res; 2001 Feb; 61(4):1727-32. PubMed ID: 11245489
[TBL] [Abstract][Full Text] [Related]
3. Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis.
Ilan N; Elkin M; Vlodavsky I
Int J Biochem Cell Biol; 2006; 38(12):2018-39. PubMed ID: 16901744
[TBL] [Abstract][Full Text] [Related]
4. Regulation of heparanase gene expression by estrogen in breast cancer.
Elkin M; Cohen I; Zcharia E; Orgel A; Guatta-Rangini Z; Peretz T; Vlodavsky I; Kleinman HK
Cancer Res; 2003 Dec; 63(24):8821-6. PubMed ID: 14695198
[TBL] [Abstract][Full Text] [Related]
5. Central role of p53 on regulation of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) expression in mammary carcinoma.
Pal S; Datta K; Mukhopadhyay D
Cancer Res; 2001 Sep; 61(18):6952-7. PubMed ID: 11559575
[TBL] [Abstract][Full Text] [Related]
6. HSulf-1 inhibits angiogenesis and tumorigenesis in vivo.
Narita K; Staub J; Chien J; Meyer K; Bauer M; Friedl A; Ramakrishnan S; Shridhar V
Cancer Res; 2006 Jun; 66(12):6025-32. PubMed ID: 16778174
[TBL] [Abstract][Full Text] [Related]
7. Heparanase affects adhesive and tumorigenic potential of human glioma cells.
Zetser A; Bashenko Y; Miao HQ; Vlodavsky I; Ilan N
Cancer Res; 2003 Nov; 63(22):7733-41. PubMed ID: 14633698
[TBL] [Abstract][Full Text] [Related]
8. Repression of vascular endothelial growth factor expression by the zinc finger transcription factor ZNF24.
Harper J; Yan L; Loureiro RM; Wu I; Fang J; D'Amore PA; Moses MA
Cancer Res; 2007 Sep; 67(18):8736-41. PubMed ID: 17875714
[TBL] [Abstract][Full Text] [Related]
9. Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis.
Edovitsky E; Elkin M; Zcharia E; Peretz T; Vlodavsky I
J Natl Cancer Inst; 2004 Aug; 96(16):1219-30. PubMed ID: 15316057
[TBL] [Abstract][Full Text] [Related]
10. Tristetraprolin down-regulates interleukin-8 and vascular endothelial growth factor in malignant glioma cells.
Suswam E; Li Y; Zhang X; Gillespie GY; Li X; Shacka JJ; Lu L; Zheng L; King PH
Cancer Res; 2008 Feb; 68(3):674-82. PubMed ID: 18245466
[TBL] [Abstract][Full Text] [Related]
11. Analysis of hypoxia-related gene expression in sarcomas and effect of hypoxia on RNA interference of vascular endothelial cell growth factor A.
Detwiller KY; Fernando NT; Segal NH; Ryeom SW; D'Amore PA; Yoon SS
Cancer Res; 2005 Jul; 65(13):5881-9. PubMed ID: 15994966
[TBL] [Abstract][Full Text] [Related]
12. ErbB2 increases vascular endothelial growth factor protein synthesis via activation of mammalian target of rapamycin/p70S6K leading to increased angiogenesis and spontaneous metastasis of human breast cancer cells.
Klos KS; Wyszomierski SL; Sun M; Tan M; Zhou X; Li P; Yang W; Yin G; Hittelman WN; Yu D
Cancer Res; 2006 Feb; 66(4):2028-37. PubMed ID: 16489002
[TBL] [Abstract][Full Text] [Related]
13. Regulation of vascular endothelial growth factor expression by EMMPRIN via the PI3K-Akt signaling pathway.
Tang Y; Nakada MT; Rafferty P; Laraio J; McCabe FL; Millar H; Cunningham M; Snyder LA; Bugelski P; Yan L
Mol Cancer Res; 2006 Jun; 4(6):371-7. PubMed ID: 16778084
[TBL] [Abstract][Full Text] [Related]
14. Coexpression of heparanase, basic fibroblast growth factor and vascular endothelial growth factor in human esophageal carcinomas.
Mikami S; Ohashi K; Katsube K; Nemoto T; Nakajima M; Okada Y
Pathol Int; 2004 Aug; 54(8):556-63. PubMed ID: 15260846
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of Cx43 by retroviral delivery of small interfering RNA promotes an aggressive breast cancer cell phenotype.
Shao Q; Wang H; McLachlan E; Veitch GI; Laird DW
Cancer Res; 2005 Apr; 65(7):2705-11. PubMed ID: 15805269
[TBL] [Abstract][Full Text] [Related]
16. Mutual enhancement between heparanase and vascular endothelial growth factor: a novel mechanism for melanoma progression.
Luan Q; Sun J; Li C; Zhang G; Lv Y; Wang G; Li C; Ma C; Gao T
Cancer Lett; 2011 Sep; 308(1):100-11. PubMed ID: 21624769
[TBL] [Abstract][Full Text] [Related]
17. HOXB7: a key factor for tumor-associated angiogenic switch.
Carè A; Felicetti F; Meccia E; Bottero L; Parenza M; Stoppacciaro A; Peschle C; Colombo MP
Cancer Res; 2001 Sep; 61(17):6532-9. PubMed ID: 11522651
[TBL] [Abstract][Full Text] [Related]
18. COX-2 induction by heparanase in the progression of breast cancer.
Imada T; Matsuoka J; Nobuhisa T; Okawa T; Murata T; Tabuchi Y; Shirakawa Y; Ohara N; Gunduz M; Nagatsuka H; Umeoka T; Yamamoto Y; Nakajima M; Tanaka N; Naomoto Y
Int J Mol Med; 2006 Feb; 17(2):221-8. PubMed ID: 16391819
[TBL] [Abstract][Full Text] [Related]
19. Heparanase induces tissue factor pathway inhibitor expression and extracellular accumulation in endothelial and tumor cells.
Nadir Y; Brenner B; Gingis-Velitski S; Levy-Adam F; Ilan N; Zcharia E; Nadir E; Vlodavsky I
Thromb Haemost; 2008 Jan; 99(1):133-41. PubMed ID: 18217145
[TBL] [Abstract][Full Text] [Related]
20. Mammalian heparanase as mediator of tumor metastasis and angiogenesis.
Vlodavsky I; Elkin M; Pappo O; Aingorn H; Atzmon R; Ishai-Michaeli R; Aviv A; Pecker I; Friedmann Y
Isr Med Assoc J; 2000 Jul; 2 Suppl():37-45. PubMed ID: 10909416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
